Tag: AdoShell
Adocia: positive results for the antidiabetic hydrogel AdoShell Islets
(AOF) – Adocia announces that it has revealed additional results on AdoShell Islets, an immunoprotective hydrogel containing Langerhans islets for the treatment of diabetes by cell therapy, during recent international…
ADOCIA announces oral presentations on AdoShell® Islets during the EASD and IPITA-IXA-CTRMS congresses – 09/25/2023 at 6:00 p.m.
6:00 p.m. CEST – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions for the treatment of diabetes and…